参考文献
[1]Conrad K, Röber N, Andrade L EC, et al.The clinical relevance of anti-DFS70 autoantibodies[J].Clinical reviews in allergy & immunology,2017, 52(2): 202—216.
[2]Mahler M, Andrade LE, Casiano CA, et al.Anti-DFS70 antibody: an update on our current understanding and their clinical usefulness[J].Expert review of clinical immunology, 2019, 15(3): 241—250.
[3]Bentow C, Fritzler MJ, Mummert E, et al.Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey[J].Autoimmunity Highlights, 2016, 7(1): 1—7.
[4]Shiboski CH, Shiboski SC, Seror R, et al.2016 American College of Rheumatology/European League Against Rheumatism classif ication criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts[J].Annals of the rheumatic diseases, 2017, 76(1): 9—16.
[5]Novak GV, Marques M, Balbi V, et al.Anti-RO/SSA and anti-La/SSB antibody: Association with mild lupus manifestations in 645 childhoodonset systemic lupus erythematosus[J].Autoimmunity reviews, 2017, 16(2): 132—135.
[6]Peene I, Van Ael W, Vandenbossche M, et al.Sensitivity of the HEp—2000 substrate for the detection of anti-SSA/Ro60 antibody[J].Clinical rheumatology, 2000, 19(4): 291—295.
[7]Shoenfeld, Y, Meroni, PL, Gershwin ME, et al.Autoantibodies[M].3rd Amsterdam: Elsevier， 2014.
[8]Brito-Zeron P, Baldini C, Bootsma H, et al.Sjögren syndrome[J].Nature reviews Disease primers, 2016, 2(1): 1—20.
[9]Kapogiannis B, Gussin HAE, Teodorescu MR, et al.Diあ erences in clinical sensitivity of ELISA tests for autoantibodies with human and bovine extractable nuclear antigens[J].Lupus, 2000, 9(5): 343—352.
[10]Richards M, García-De La Torre I, Gonzalez-Bello YC, et al.Autoantibodies to Mi—2 alpha and Mi—2 beta in patients with idiopathic inf lammatory myopathy[J].Rheumatology, 2019, 58(9): 1655—1661.
[11]Pinal-Fernandez I, Pak K, Casal-Dominguez M, et al.Validation of anti-Mi2 autoantibody testing by line blot[J].Autoimmunity reviews, 2020,19(1): 102425.
[12]Low A H L, Wong S, Thumboo J, et al.Evaluation of a new multi-parallel line immunoassay for systemic sclerosis-associated antibody in an Asian population[J].Rheumatology, 2012, 51(8): 1465—1470.
[13]Wang J, Satoh M, Kabir F, et al.Increased prevalence of autoantibodies to ku antigen in African American versus white patients with systemic lupus erythematosus[J].Arthritis & Rheumatism, 2001, 44(10): 2367—2370.
[14]Fujimoto M, Watanabe R, Ishitsuka Y, et al.Recent advances in dermatomyositis-specif ic autoantibodies[J].Current opinion in rheumatology,2016, 28(6): 636—644.
[15]Oldroyd A, Sergeant JC, New P, et al.The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis[J].Rheumatology, 2019, 58(4): 650—655.
[16]Labrador-Horrillo M, Martínez MA, Selva-O’Callaghan A, et al.Anti-TIF1γ antibody (anti-p155) in adult patients with dermatomyositis:comparison of diあ erent diagnostic assays[J].Annals of the rheumatic diseases, 2012, 71(6): 993—996.
[17]Sharp GC, Irvin WS, Tan EM, et al.Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specif ic antibody to an extractable nuclear antigen (ENA)[J].The American journal of medicine, 1972, 52(2): 148—159.
[18]Hu C, Li M, Liu J, et al.Anti-SmD1 antibody are associated with renal disorder, seizures, and pulmonary arterial hypertension in Chinese patients with active SLE[J].Scientif ic Reports, 2017, 7(1): 1—8.
[19]Salmhofer W, Hermann J, Joch M, et al.High serum levels of antibody against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease[J].Journal of the European Academy of Dermatology and Venereology, 2007, 21(8): 1047—1053.
[20]Okano Y, Steen VD, Medsger TA.Autoantibody reactive with RNA polymerase Ⅲ in systemic sclerosis[J].Annals of internal medicine, 1993,119(10): 1005—1013.
[21]Steen VD.Autoantibodies in systemic sclerosis[J].Seminars in arthritis and rheumatism, 2005, 35(1): 35—42.
[22]Kuwana M, Okano Y, Pandey JP, et al.Enzyme-linked immunosorbent assay for detection of Anti-RNA polymerase Ⅲ antibody: Analytical accuracy and clinical associations in systemic sclerosis[J].Arthritis & Rheumatism: Oき cial Journal of the American College of Rheumatology,2005, 52(8): 2425—2432.
[23]Santiago M, Baron M, Hudson M, et al.Antibody to RNA polymerase Ⅲ in systemic sclerosis detected by ELISA[J].The Journal of Rheumatology, 2007, 34(7): 1528—1534.
[24]Sieghart D, Platzer A, Studenic P, et al.Determination of autoantibody isotypes increases the sensitivity of serodiagnostics in rheumatoid arthritis[J].Frontiers in immunology, 2018, 9: 876.
[25]Sueoka E, Yukitake M, Iwanaga K, et al.Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients[J].Annals of Neurology: Oき cial Journal of the American Neurological Association and the Child Neurology Society, 2004, 56(6): 778—786.
[26]Kuwana M, Kaburaki J, Mimori T, et al.Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis[J].Arthritis &Rheumatism: Oき cial Journal of the American College of Rheumatology, 2000, 43(5): 1074—1084.
[27]Quismorio Jr FP, Torralba KD.Clinical Application of Serologic Tests, Serum Protein Abnormalities, and Other Clinical Laboratory Tests in SLE[M], Dubois’ Lupus Erythematosus and Related Syndromes.WB Saunders, 2013: 526—540.
[28]Bizzaro N, Tonutti E, Villalta D, et al.Sensitivity and specif icity of immunological methods for the detection of anti-topoisomerase I (Scl70)autoantibodies: results of a multicenter study[J].Clinical chemistry, 2000, 46(10): 1681—1685.